Vitamin E status in children with cystic fibrosis and pancreatic insufficiency

J Pediatr. 2006 Apr;148(4):556-559. doi: 10.1016/j.jpeds.2005.11.016.

Abstract

Vitamin E status was compared in 69 children (7.0-10.0 years) with cystic fibrosis and pancreatic with the National Health and Nutrition Examination Survey III sample (6.0-11.9 years). With median vitamin E intakes of 6 mg/day (dietary) and 224 mg/day (supplemental), children with cystic fibrosis had higher serum alpha-tocopherol:cholesterol ratios, higher alpha-tocopherol, and lower cholesterol levels than in the National Health and Nutrition Examination Survey.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Cholesterol / blood
  • Cross-Sectional Studies
  • Cystic Fibrosis / blood*
  • Cystic Fibrosis / drug therapy
  • Dietary Supplements
  • Exocrine Pancreatic Insufficiency / blood*
  • Exocrine Pancreatic Insufficiency / drug therapy
  • Female
  • Humans
  • Male
  • United States
  • Vitamin E / blood*
  • Vitamin E / therapeutic use
  • Vitamin E Deficiency / prevention & control*
  • alpha-Tocopherol / blood

Substances

  • Vitamin E
  • Cholesterol
  • alpha-Tocopherol